Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30195% above fair value
$42.60+0.74 (+1.77%)
Close on Nov 13, 2026Market cap $1.99BP/E –Yield –
Septerna enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Septerna's enterprise value was $1.85B on Nov 11, 2026, against $821.07M a year earlier. Over the last 2 years it ranged from -$93.72M to $1.85B, with a median of $591.54M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.85B | +139.6% |
| 2025 | Dec 31, 2025 | $770.18M | – |
| 2024 | Dec 31, 2024 | -$72.50M | – |
See a number that looks wrong?